chr18-60372043-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_005912.3(MC4R):c.307G>A(p.Val103Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0182 in 1,614,174 control chromosomes in the GnomAD database, including 281 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 14 hom., cov: 32)
Exomes 𝑓: 0.018 ( 267 hom. )
Consequence
MC4R
NM_005912.3 missense
NM_005912.3 missense
Scores
1
3
14
Clinical Significance
Conservation
PhyloP100: 6.14
Genes affected
MC4R (HGNC:6932): (melanocortin 4 receptor) The protein encoded by this gene is a membrane-bound receptor and member of the melanocortin receptor family. The encoded protein interacts with adrenocorticotropic and MSH hormones and is mediated by G proteins. This is an intronless gene. Defects in this gene are a cause of autosomal dominant obesity. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
PM1
In a helix (size 28) in uniprot entity MC4R_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_005912.3
BP4
Computational evidence support a benign effect (MetaRNN=0.0067133605).
BP6
Variant 18-60372043-C-T is Benign according to our data. Variant chr18-60372043-C-T is described in ClinVar as [Benign]. Clinvar id is 218330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-60372043-C-T is described in Lovd as [Benign]. Variant chr18-60372043-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0154 (2350/152308) while in subpopulation SAS AF= 0.0243 (117/4816). AF 95% confidence interval is 0.0207. There are 14 homozygotes in gnomad4. There are 1116 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2350 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC4R | NM_005912.3 | c.307G>A | p.Val103Ile | missense_variant | 1/1 | ENST00000299766.5 | NP_005903.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC4R | ENST00000299766.5 | c.307G>A | p.Val103Ile | missense_variant | 1/1 | NM_005912.3 | ENSP00000299766 | P1 | ||
ENST00000658928.1 | n.156+42698C>T | intron_variant, non_coding_transcript_variant | ||||||||
ENST00000650201.1 | n.113+42698C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0154 AC: 2350AN: 152190Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
2350
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0161 AC: 4057AN: 251448Hom.: 49 AF XY: 0.0167 AC XY: 2276AN XY: 135896
GnomAD3 exomes
AF:
AC:
4057
AN:
251448
Hom.:
AF XY:
AC XY:
2276
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0185 AC: 26996AN: 1461866Hom.: 267 Cov.: 32 AF XY: 0.0186 AC XY: 13508AN XY: 727236
GnomAD4 exome
AF:
AC:
26996
AN:
1461866
Hom.:
Cov.:
32
AF XY:
AC XY:
13508
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0154 AC: 2350AN: 152308Hom.: 14 Cov.: 32 AF XY: 0.0150 AC XY: 1116AN XY: 74482
GnomAD4 genome
AF:
AC:
2350
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
1116
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
66
ALSPAC
AF:
AC:
65
ESP6500AA
AF:
AC:
79
ESP6500EA
AF:
AC:
159
ExAC
AF:
AC:
2116
Asia WGS
AF:
AC:
49
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Uncertain:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Obesity Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital | Sep 18, 2014 | - - |
protective, no assertion criteria provided | case-control | UCL Genetics Institute, UCL | Dec 23, 2014 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | - - |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Imperial College London Diabetes Centre, Mubadala Healthcare | May 01, 2020 | - - |
MELANOCORTIN 4 RECEPTOR POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Apr 01, 1999 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Jan 18, 2019 | ACMG criteria: BP4 (REVEL 0.050 + 6 predictors; not using PP3/4 predictors), BA1 (overall MAF in gnomAD 1.6%; over 2% in multiple subpop), BS2 (51 homozygotes in gnomAD, 237 cases and 277 controls in type2diabetesgenetics.org)=benign - |
OBESITY, RESISTANCE TO Benign:1
protective, no assertion criteria provided | literature only | OMIM | Apr 01, 1999 | - - |
MC4R-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 08, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at